JPH0443697B2 - - Google Patents

Info

Publication number
JPH0443697B2
JPH0443697B2 JP61202661A JP20266186A JPH0443697B2 JP H0443697 B2 JPH0443697 B2 JP H0443697B2 JP 61202661 A JP61202661 A JP 61202661A JP 20266186 A JP20266186 A JP 20266186A JP H0443697 B2 JPH0443697 B2 JP H0443697B2
Authority
JP
Japan
Prior art keywords
urea
group
imidazole
adsorbent
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61202661A
Other languages
Japanese (ja)
Other versions
JPS6359353A (en
Inventor
Masayuki Mishima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kao Corp
Original Assignee
Kao Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kao Corp filed Critical Kao Corp
Priority to JP61202661A priority Critical patent/JPS6359353A/en
Publication of JPS6359353A publication Critical patent/JPS6359353A/en
Publication of JPH0443697B2 publication Critical patent/JPH0443697B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • External Artificial Organs (AREA)

Description

【発明の詳现な説明】 〔産業䞊の利甚分野〕 本発明は尿玠吞着剀に関し、特に人工腎臓に有
甚な新芏高分子尿玠吞着剀に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a urea adsorbent, and particularly to a novel polymeric urea adsorbent useful for artificial kidneys.

〔埓来の技術および発明が解決しようずする問題点〕[Problems to be solved by conventional technology and invention]

珟圚、人工腎臓ずしお甚いられおいるものずし
おは、透析型、ろ過型、吞着型及び酵玠固定型人
工腎臓が挙げられる。
Artificial kidneys currently in use include dialysis-type, filtration-type, adsorption-type, and enzyme-immobilized artificial kidneys.

しかしながら、これらはいずれも䞀長䞀短を有
しおおり、慢性、急性腎䞍党患者に察しお満足の
できるものは開発されおいない。
However, all of these have advantages and disadvantages, and no drug has been developed that is satisfactory for patients with chronic or acute renal failure.

䟋えば透析型人工腎臓は、珟圚最も普及されお
いるものであるが、垞に新しい透析液が必芁ずな
る。又、䞀般にこのものは装眮が倧型で腎䞍党患
者が長時間病院内に拘束されるずいう䞍䟿さが生
じる。
For example, dialysis-type artificial kidneys are currently the most popular, but new dialysate is always required. In addition, these devices are generally large in size, resulting in the inconvenience that renal failure patients are confined in the hospital for long periods of time.

ろ過型人工腎臓では、有甚な成分を含む血枅を
も廃棄しおしたうずいう倧きな欠点を有しおい
る。
Filtration-type artificial kidneys have a major drawback in that serum containing useful components is also discarded.

酵玠固定型人工腎臓は、最近、特に開発が進ん
でいるものであるが、りレアヌれ固定時又は固定
埌の酵玠掻性の倱掻が問題であり、又、その性胜
も枩床、酞性床等の呚囲の環境に圱響されやす
い。
Enzyme-immobilized artificial kidneys have been in particular progress in development recently, but there is a problem with the inactivation of the enzyme activity during or after urease immobilization, and its performance also depends on the surrounding environment such as temperature and acidity. Easily influenced by the environment.

吞着型人工腎臓は小型軜量で簡䟿なものである
が、吞着剀ずしお掻性炭が甚いられおおり、有機
性老廃物には有効であるが、尿䞭に排泄される最
倧成分である尿玠には党く効力が無い。珟圚、吞
着型人工腎臓においおは、尿玠陀去物質の探玢が
最も重芁な課題にな぀おいる。䟋えば酞化デンプ
ンの応甚高分子論文集、第39巻、第629頁、ヒ
ドラゞド基を有する重合䜓にホルムアルデヒド又
はグリオキザヌルを反応させおなる尿玠吞着剀
特開昭51−69489号公報等が挙げられるが、実
甚の段階には達しおいないのが実情である。
Adsorption-type artificial kidneys are small, lightweight, and simple, but they use activated carbon as an adsorbent, and although they are effective for organic wastes, they are completely ineffective against urea, which is the largest component excreted in urine. It has no effect. Currently, the search for urea removal substances is the most important issue in adsorption artificial kidneys. For example, there are applications of oxidized starch (Kobunshi Ronshu, Vol. 39, p. 629), urea adsorbents made by reacting formaldehyde or glyoxal with a polymer having a hydrazide group (Japanese Patent Application Laid-open No. 1983-69489), etc. However, the reality is that it has not yet reached the stage of practical use.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者は前蚘の問題点を解決すべく高性胜尿
所吞着剀に぀いお鋭意怜蚎した結果、尿玠陀去物
質ずしおカルボキシル基ずむミダゟヌル基の䞡基
を含む重合䜓が有甚であり、曎にポリオキシアル
キレングリコヌル誘導䜓を構成成分ずしお含む重
合䜓がより䞀局の尿玠吞着胜を有する事実を芋出
し、本発明に至぀たのである。すなわち本発明
は、 (1) カルボキシル基ず䞀般匏(1)で瀺されるむミダ
ゟヌル基 匏䞭、R1は氎玠たたは炭玠数以䞋の炭化
氎玠基を衚す。 を構成成分ずしお含有し、必芁に応じお架橋剀
により架橋した゚チレン性䞍飜和単量䜓の重合
䜓であ぀お、カルボキシル基の数ずむミダゟヌ
ル基の数ずの比カルボキシル基むミダゟヌ
ル基が、0.1乃至8.0であるこずを特城ずする
高分子尿玠吞着剀。
As a result of intensive studies on high-performance urinary adsorbents to solve the above-mentioned problems, the present inventor found that a polymer containing both carboxyl groups and imidazole groups is useful as a urea removal substance, and polyoxyalkylene glycol The inventors discovered that a polymer containing a derivative as a constituent component has a higher urea adsorption ability, leading to the present invention. That is, the present invention provides: (1) a carboxyl group and an imidazole group represented by general formula (1); (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.) A polymer of ethylenically unsaturated monomers that contains as a constituent component and is crosslinked with a crosslinking agent as necessary. , a polymer urea adsorbent characterized in that the ratio of the number of carboxyl groups to the number of imidazole groups (carboxyl group/imidazole group) is from 0.1 to 8.0.

(2)カルボキシル基、 䞀般匏(1)で瀺されるむミダゟヌル基 匏䞭、R1は氎玠たたは炭玠数以䞋の炭化氎
玠基を衚す。、及び 䞀般匏(2) 〔−CH2−o−〕nR2 (2) 匏䞭は乃至の敎数、は以䞊の敎数を
衚し、R2は氎玠たたはメチル基を衚す。で瀺さ
れるポリオキシアルキレングリコヌル誘導䜓基を
構成成分ずしお含有し、必芁に応じお架橋剀によ
り架橋した゚チレン性䞍飜和単量䜓の重合䜓であ
぀お、カルボキシル基ずむミダゟヌル基の数ずの
比カルボキシル基むミダゟヌル基が、0.1
乃至8.0であるこずを特城ずする高分子尿玠吞着
剀に関する。
(2) Carboxyl group, imidazole group represented by general formula (1) (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.), and General formula (2) [-(CH 2 -) o O-] n R 2 (2) (In the formula, n is Contains a polyoxyalkylene glycol derivative group represented by an integer of 2 to 5, m represents an integer of 3 or more, and R2 represents hydrogen or a methyl group as a constituent component, and can be crosslinked with a crosslinking agent as necessary. A polymer of ethylenically unsaturated monomers having a ratio of the number of carboxyl groups to imidazole groups (carboxyl group/imidazole group) of 0.1.
The present invention relates to a polymer urea adsorbent characterized in that it has a molecular weight of 8.0 to 8.0.

本発明の尿玠吞着剀は以䞋の方法により容易に
補造できる。即ち、カルボキシル基を有する゚チ
レン性䞍飜和単量䜓もしくはカルボキシル基に倉
換可胜な基を有する゚チレン性䞍飜和単量䜓ず䞀
般匏(1)に瀺すむミダゟヌル基を有する゚チレン性
䞍飜和単量䜓をある䞀定のモル比で混合し、又は
さらに他の゚チレン性䞍飜和単量䜓を远加し、ラ
ゞカル重合法により補造される。その補造法は任
意であり、特に限定されるものではなく、塊状重
合法、溶液重合法、乳化重合法、懞濁重合法いず
れの方法においおも補造するこずができる。
The urea adsorbent of the present invention can be easily produced by the following method. That is, an ethylenically unsaturated monomer having a carboxyl group or a group convertible to a carboxyl group and an ethylenically unsaturated monomer having an imidazole group shown in general formula (1). It is produced by radical polymerization by mixing at a certain molar ratio or by adding other ethylenically unsaturated monomers. The manufacturing method is arbitrary and is not particularly limited, and it can be manufactured by any of the bulk polymerization method, solution polymerization method, emulsion polymerization method, and suspension polymerization method.

カルボキシル基を有する゚チレン性䞍飜和単量
䜓ずしおは、具䜓的にアクリル酞、メタクリル
酞、クロトン酞、む゜クロトン酞、−ペンテン
酞、−゚チルアクリル酞、アンゞ゚リカ酞、チ
グリン酞、−ゞメチルアクリル酞、−プ
ロピルアクリル酞、−む゜プロピルアクリル
酞、トリメチルアクリル酞、−ブチルアクリル
酞、−ブチルアクリル酞、−メチル−−ヘ
キセン酞、−ゞ゚チルアクリル酞、−オ
クテン酞、−ノネン酞、−デセン酞、α−ア
セトキシアクリル酞等のアクリル系䞍飜和単量
䜓、−ビニル安息銙酞、−ビニル安息銙酞、
−ビニルサリチル酞、−ビニルサリチル酞、
−ビニルサリチル酞、−ビニルアセチルサリ
チル酞、−ビニルアセチルサリチル酞、−ビ
ニルアセチルサリチル酞等のスチレン系䞍飜和単
量䜓、マレむン酞、メチルマレむン酞、ゞメチル
マレむン酞、プニルマレむン酞等の二官胜性䞍
飜和単量䜓等をあげるこずができ、䞀皮もしくは
二皮以䞊のものを組み合せお䜿甚するこずができ
る。
Examples of the ethylenically unsaturated monomer having a carboxyl group include acrylic acid, methacrylic acid, crotonic acid, isocrotonic acid, 2-pentenoic acid, 2-ethyl acrylic acid, andieric acid, tiglic acid, 3,3- Dimethyl acrylic acid, 3-propylacrylic acid, 3-isopropylacrylic acid, trimethylacrylic acid, 2-butylacrylic acid, 3-butylacrylic acid, 2-methyl-2-hexenoic acid, 2,3-diethylacrylic acid, 2 - Acrylic unsaturated monomers such as octenoic acid, 2-nonenoic acid, 2-decenoic acid, α-acetoxyacrylic acid, o-vinylbenzoic acid, p-vinylbenzoic acid,
3-vinylsalicylic acid, 4-vinylsalicylic acid,
Styrenic unsaturated monomers such as 5-vinylsalicylic acid, 3-vinylacetylsalicylic acid, 4-vinylacetylsalicylic acid, and 5-vinylacetylsalicylic acid; Examples include functional unsaturated monomers, which can be used singly or in combination of two or more.

カルボキシル基に倉換可胜な基を有する゚チレ
ン性䞍飜和単量䜓ずは、䞊蚘カルボキシル基を含
む゚チレン性䞍飜和単量䜓の酞ハロゲン化物、酞
無氎物、アルキル゚ステル化物、酞アミド化物、
酞むミド化物、酞ヒドラゞド化物、酞無機塩等や
α−アンゞ゚リカラクトン、α−メチレン−γ−
ブチロラクトン、5H−フラノン等の䞍飜和
ラクトン、アクリロニトリル、メタクリロニトリ
ル等の䞍飜和ニトリル等も䜿甚するこずができ、
重合埌いずれも加氎分解凊理によりカルボキシル
基に倉換するこずが可胜である。又、重合埌酞化
反応によりカルボキシル基を導入するこずも可胜
であるが、䞻鎖の切断やむミダゟヌル基の開環反
応等の奜たしくない副反応が匕き起されるため、
本発明においおは奜たしくない。
Ethylenically unsaturated monomers having a group convertible to a carboxyl group include acid halides, acid anhydrides, alkyl esters, acid amides,
Acid imidides, acid hydrazides, acid inorganic salts, α-angiericalactone, α-methylene-γ-
Unsaturated lactones such as butyrolactone and 2(5H)-furanone, unsaturated nitriles such as acrylonitrile and methacrylonitrile, etc. can also be used.
After polymerization, any of them can be converted into carboxyl groups by hydrolysis treatment. It is also possible to introduce a carboxyl group by an oxidation reaction after polymerization, but this causes undesirable side reactions such as cleavage of the main chain and ring-opening reaction of the imidazole group.
This is not preferred in the present invention.

むミダゟヌル基を有する゚チレン性䞍飜和単量
䜓ずは、䟋えば−ビニルむミダゟヌル、−ビ
ニルむミダゟヌル、−ビニルむミダゟヌル、
−メチル−−ビニルむミダゟヌル、−メチル
−−ビニルむミダゟヌル、−゚チル−−ビ
ニルむミダゟヌル、−プロピル−−ビニルむ
ミダゟヌル、−ブチル−−ビニルむミダゟヌ
ル等をあげるこずができ、䞀皮もしくは二皮以䞊
のものを組み合せお䜿甚するこずができる。
The ethylenically unsaturated monomer having an imidazole group is, for example, 1-vinylimidazole, 2-vinylimidazole, 4-vinylimidazole, 1
-Methyl-2-vinylimidazole, 1-methyl-5-vinylimidazole, 1-ethyl-5-vinylimidazole, 1-propyl-5-vinylimidazole, 1-butyl-5-vinylimidazole, etc. One type or a combination of two or more types can be used.

カルボキシル基を有する゚チレン性䞍飜和単量
䜓もしくはカルボキシル基に倉換可胜な基を有す
る゚チレン性䞍飜和単量䜓ず、むミダゟヌル基を
有する゚チレン性䞍飜和単量䜓ずからたずアシル
むミダゟヌルを合成し、このものを重合し、重合
埌加氎分解するこずにより、遊離のカルボキシル
基ずむミダゟヌル基に倉換する方法も有効であり
䜿甚するこずができる。
First, an acylimidazole is synthesized from an ethylenically unsaturated monomer having a carboxyl group or an ethylenically unsaturated monomer having a group convertible to a carboxyl group, and an ethylenically unsaturated monomer having an imidazole group, A method of converting this product into free carboxyl groups and imidazole groups by polymerizing it and hydrolyzing it after the polymerization is also effective and can be used.

本発明においおは、他の゚チレン性䞍飜和単量
䜓をも必芁に応じお重合䜓の補造に䜿甚するこず
ができ、これらはたずえカルボン酞誘導䜓であ぀
おも、重合埌カルボキシル基に倉換する必芁のな
いものであ぀お、䟋えば、゚チレン、プロピレ
ン、−ブテン、−ブテン、−ヘキセン、
−゚チル−−ブテン、−メチルシクロペンテ
ン、−ヘプテン、−ヘプテン、−メチル−
−ヘキセン、シクロヘプテン、−オクテン、
−オクテン、−ノネン、−ブテン、−ノ
ネン、−ノネン、−プニル−−ペンテ
ン、α−ピネン、β−ピネン等のオレフむン系䞍
飜和単量䜓、クロロ゚チレン、プロモ゚チレン、
−ゞクロロ゚チレン、−ゞクロロ゚
チレン、トリフルオロ゚チレン等のハロゲン化゚
チレン系䞍飜和単量䜓、スチレン、−メチルス
チレン、−メチルスチレン、−メチルスチレ
ン、−゚チルスチレン、−゚チルスチレ、
−゚チルスチレン、−クロロスチレン、−ク
ロロスチレン、−クロロスチレン、−クロロ
メチルスチレン、−クロロメチルスチレン、
−メトキシスチレン、−メトキシスチレン、
−メトキシスチレン、−ニトロスチレン、−
ニトロスチレン、−ニトロスチレン、−シア
ノスチレン、−シアノスチレン、−シアノス
チレン等のスチレン系䞍飜和単量䜓、メチルビニ
ル゚ヌテル、゚チルビニル゚ヌテル、−プロピ
ルビニル゚ヌテル、−プロピルビニル゚ヌテ
ル、−ブチルビニル゚ヌテル、sec−ブチルビ
ニル゚ヌテル、−ブチルビニル゚ヌテル、プ
ニルビニル゚ヌテル等のビニル゚ヌテル系䞍飜和
単量䜓、メチルビニルケトン、アセトキシビニル
ケトン、゚チルビニルケトン、−プロピルビニ
ルケトン、−プロピルビニルケトン、プニル
ビニルケトン等のビニルケトン系䞍飜和単量䜓、
酢酞ビニル、゚トキシ酢酞ビニル、プロピオン酞
ビニル、酪酞ビニル、ラりリル酞ビニル、パルミ
チン酞ビニル、ステアリン酞ビニル等のビニル゚
ステル系䞍飜和単量䜓、メタアクリル酞メチ
ル、メタアクリル酞゚チル、メタアクリル
酞−−プロピル、メタアクリル酞−ブチ
ル、メタアクリル酞−アミル、メタアク
リル酞−ヘキシル、メタアクリル酞オクチ
ル、メタアクリル酞ノニル、メタアクリル
酞デシル、メタアクリル酞ドデシル、メタ
アクリル酞オレむル、メタアクリル酞グリシ
ゞル等のメタアクリル酞゚ステル系単量䜓、
その他、無氎マレむン酞、アクリルニトリル、ア
クリルアミド等の単量䜓を必芁に応じお䜿甚する
こずができ、これらの䞀皮もしくは二皮以䞊を䜿
甚するこずができる。
In the present invention, other ethylenically unsaturated monomers can also be used in the production of the polymer if necessary, and even if they are carboxylic acid derivatives, they need to be converted into carboxyl groups after polymerization. For example, ethylene, propylene, 1-butene, 2-butene, 1-hexene, 2
-ethyl-1-butene, 1-methylcyclopentene, 1-heptene, 2-heptene, 2-methyl-
1-hexene, cycloheptene, 1-octene,
Olefinic unsaturated monomers such as 2-octene, 1-nonene, 1-butene, 2-nonene, 3-nonene, 1-phenyl-2-pentene, α-pinene, β-pinene, chloroethylene, promoethylene ,
Halogenated ethylenically unsaturated monomers such as 1,1-dichloroethylene, 1,2-dichloroethylene, trifluoroethylene, styrene, o-methylstyrene, m-methylstyrene, p-methylstyrene, o-ethylstyrene, m -ethyl styrene, p
-ethylstyrene, o-chlorostyrene, m-chlorostyrene, p-chlorostyrene, m-chloromethylstyrene, p-chloromethylstyrene, o
-methoxystyrene, m-methoxystyrene, p
-methoxystyrene, o-nitrostyrene, m-
Styrenic unsaturated monomers such as nitrostyrene, p-nitrostyrene, o-cyanostyrene, m-cyanostyrene, p-cyanostyrene, methyl vinyl ether, ethyl vinyl ether, n-propyl vinyl ether, i-propyl vinyl ether, n- Vinyl ether unsaturated monomers such as butyl vinyl ether, sec-butyl vinyl ether, t-butyl vinyl ether, phenyl vinyl ether, methyl vinyl ketone, acetoxy vinyl ketone, ethyl vinyl ketone, n-propyl vinyl ketone, i-propyl vinyl ketone, Vinyl ketone unsaturated monomers such as phenyl vinyl ketone,
Vinyl ester unsaturated monomers such as vinyl acetate, ethoxyvinyl acetate, vinyl propionate, vinyl butyrate, vinyl laurate, vinyl palmitate, vinyl stearate, methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, n-butyl (meth)acrylate, n-amyl (meth)acrylate, n-hexyl (meth)acrylate, octyl (meth)acrylate, nonyl (meth)acrylate , (meth)decyl acrylate, (meth)dodecyl acrylate, (meth)
(meth)acrylic acid ester monomers such as oleyl acrylate and glycidyl (meth)acrylate;
In addition, monomers such as maleic anhydride, acrylonitrile, and acrylamide can be used as required, and one or more of these monomers can be used.

特に、他の゚チレン性䞍飜和単量䜓ずしお、䞀
般匏(3)又は(4) 匏䞭、は乃至の敎数、は以䞊の敎数
であり、R3は氎玠もしくはメチル基、R4は氎玠
もしくは炭玠数乃至10の炭化氎玠基を瀺す。 で瀺されるラゞカル重合性ポリオキシアルキレン
グリコヌル誘導䜓を重合䜓の補造に甚いるず、䞀
般匏(2)で瀺されるポリオキシアルキレングリコヌ
ル誘導䜓基を構成成分ずしお含む重合䜓を埗るこ
ずができる。
In particular, as other ethylenically unsaturated monomers, general formula (3) or (4) (In the formula, n is an integer of 2 to 5, m is an integer of 3 or more, R 3 is hydrogen or a methyl group, and R 4 is hydrogen or a hydrocarbon group having 1 to 10 carbon atoms.) When a radically polymerizable polyoxyalkylene glycol derivative is used in the production of a polymer, a polymer containing a polyoxyalkylene glycol derivative group represented by general formula (2) as a constituent component can be obtained.

本発明で甚いられる䞀般匏(3)で瀺されるラゞカ
ル重合性ポリオキシアルキレングリコヌル誘導䜓
は、䟋えばポリオキシ゚チレングリコヌルモノ
メタアクリレヌト、ポリオキシトリメチレン
グリコヌルメタアクリレヌト、ポリオキシテ
トラメチレングリコヌルモノメタアクリレヌ
ト、ω−メトキシポリオキシ゚チレングリコヌル
モノメタアクリレヌト、ω−メトキシポリオ
キシトリメチレングリコヌルモノメタアクリ
レヌト、ω−メトキシポリオキシテトラメチレン
グリコヌルモノメタアクリレヌトであり、又
䞀般匏(4)で瀺されるラゞカル重合性ポリオキシア
ルキレングリコヌル誘導䜓は、䟋えばα−−
ビニルベンゞロキシ−ポリオキシ゚チレングリ
コヌル、α−−ビニルベンゞロキシ−ポリオ
キシトリメチレングリコヌル、α−−ビニル
ベンゞロキシ−ポリテトラメチレングリコヌル、
α−−ビニルベンゞロキシ−ω−メトキシポ
リオキシ゚チレングリコヌル、α−−ビニル
ベンゞロキシ−ω−メトキシポリオキシトリメ
チレングリコヌル、α−−ビニルベンゞロキ
シ−ω−メトキシポリオキシテトラメチレング
リコヌルである。
The radically polymerizable polyoxyalkylene glycol derivative represented by the general formula (3) used in the present invention is, for example, polyoxyethylene glycol mono(meth)acrylate, polyoxytrimethylene glycol (meth)acrylate, polyoxytetramethylene glycol mono (meth)acrylate, ω-methoxypolyoxyethylene glycol mono(meth)acrylate, ω-methoxypolyoxytrimethylene glycol mono(meth)acrylate, ω-methoxypolyoxytetramethylene glycol mono(meth)acrylate, and general The radically polymerizable polyoxyalkylene glycol derivative represented by formula (4) is, for example, α-(p-
vinylbenzyloxy)-polyoxyethylene glycol, α-(p-vinylbenzyloxy)-polyoxytrimethylene glycol, α-(p-vinylbenzyloxy)-polytetramethylene glycol,
α-(p-vinylbenzyloxy)-ω-methoxypolyoxyethylene glycol, α-(p-vinylbenzyloxy)-ω-methoxypolyoxytrimethylene glycol, α-(p-vinylbenzyloxy)-ω-methoxy It is polyoxytetramethylene glycol.

䞀般匏(3)もしくは(4)で瀺されるラゞカル重合性
ポリオキシアルキレングリコヌル誘導䜓は、他の
゚チレン性䞍飜和単量䜓ず同時に䜿甚するこずが
でき、必芁に応じお䞀皮もしくは二皮以䞊のもの
を甚いるこずができる。
The radically polymerizable polyoxyalkylene glycol derivative represented by general formula (3) or (4) can be used simultaneously with other ethylenically unsaturated monomers, and if necessary, one or more types can be used. can be used.

䞀般匏(2)で瀺されるポリオキシアルキレングリ
コヌル誘導䜓を構成成分ずしお本発明における尿
玠吞着剀に導入するこずにより、カルボキシル
基、むミダゟヌル基ずの盞乗効果により、曎に䞀
局尿玠吞着胜を発揮させるこずができる。本発明
に甚いられる䞀般匏(3)もしくは(4)で瀺されるラゞ
カル重合性ポリオキシアルキレングリコヌル誘導
䜓の数平均分子量は120以䞊であるが、奜たしく
は200以䞊であり、これよりも小さいず、その盞
乗効果は期埅できない。
By introducing the polyoxyalkylene glycol derivative represented by the general formula (2) into the urea adsorbent of the present invention as a constituent component, it is possible to further exhibit urea adsorption ability due to the synergistic effect with the carboxyl group and imidazole group. can. The number average molecular weight of the radically polymerizable polyoxyalkylene glycol derivative represented by the general formula (3) or (4) used in the present invention is 120 or more, preferably 200 or more; No synergistic effects can be expected.

本発明における高分子尿玠吞着剀の補造におい
お、必芁に応じお架橋剀も䜿甚できる。架橋剀ず
しおは䟋えばゞビニルベンれン、゚チレングリコ
ヌルメタアクリレヌト、ポリオキシ゚チレン
グリコヌルメタアクリレヌト、ポリゞメチル
シロキサンゞメタアクリレヌト、ポリアミド
ゞメタアクリレヌト等いずれも䜿甚するこず
が可胜である。架橋剀の䜿甚量は、党重量に察し
お0.01重量乃至50重量であり、それよりも倚
くなるず、補造された尿玠吞着剀の氎に察する最
滑床が著しく䜎くなり奜たしくない。又、本発明
の尿玠吞着剀は察しお䞍溶であるこずが絶察条件
であり、そのために氎に可溶である重合䜓の堎合
には、架橋剀を䜿甚しお䞍溶にする必芁がある。
叉、架橋剀を甚い無い堎合でも他の゚チレン性䞍
飜和単量䜓の量を増すこずにより䞍溶化するこず
ができ、特にオレフむン系䞍飜和単量䜓、スチレ
ン系䞍飜和単量䜓が効果的である。
In the production of the polymeric urea adsorbent in the present invention, a crosslinking agent can also be used if necessary. As the crosslinking agent, for example, divinylbenzene, ethylene glycol (meth)acrylate, polyoxyethylene glycol (meth)acrylate, polydimethylsiloxane di(meth)acrylate, polyamide di(meth)acrylate, etc. can be used. The amount of the crosslinking agent to be used is 0.01% to 50% by weight based on the total weight, and if it is more than that, the lubricity of the produced urea adsorbent with respect to water will be significantly lowered, which is not preferable. Moreover, it is an absolute condition that the urea adsorbent of the present invention is insoluble in water, and therefore, in the case of a polymer that is soluble in water, it is necessary to use a crosslinking agent to make it insoluble.
Furthermore, even if a crosslinking agent is not used, insolubilization can be achieved by increasing the amount of other ethylenically unsaturated monomers, and olefinic unsaturated monomers and styrenic unsaturated monomers are particularly effective. be.

本発明の尿玠吞着剀の補造䟋を瀺す。䟋えば、
溶液重合法の䟋を瀺すず、それぞれ等モルのメチ
ルメタクリレヌト、−ビニルむミダゟヌル、ア
クリル酞、ポリオキシ゚チレングリコヌルモノメ
タアクリレヌト、及び10モル等量の゚チレン
グリコヌルゞメタクリレヌトを溶剀に溶解し、重
合開始剀を䜿甚しお窒玠気流䞋でかきたぜを行い
重合せしめる。重合終了埌、混合物を氎に流し蟌
み重合䜓を沈柱させ、掗浄、也燥、粉砕を実斜し
高分子尿玠接着剀を調敎するこずができる。該高
分子尿玠吞着剀の構造は、カルボキシル基ずむミ
ダゟヌル基の比は仕蟌み比からず考えられ、又
䞀般匏(2)で瀺された構成成分は、党重量の58重量
であり、良奜な尿玠吞着機胜を瀺す。本発明に
おいおは、カルボキシル基を有する゚チレン性䞍
飜和単量䜓もしくはカルボキシル基に倉換可胜な
基を有する゚チレン性䞍飜和単量䜓の仕蟌み量、
及びむミダゟヌル基を有する゚チレン性䞍飜和単
量䜓の仕蟌み量はそれぞれ党仕蟌み量の重量
以䞊必芁であり、いずれか䞀方がそれ以䞋の堎合
には尿玠吞着胜は乏しく有効でない。
An example of manufacturing the urea adsorbent of the present invention will be shown. for example,
An example of the solution polymerization method is to dissolve equimolar amounts of methyl methacrylate, 1-vinylimidazole, acrylic acid, polyoxyethylene glycol monomethacrylate, and 1/10 molar equivalent of ethylene glycol dimethacrylate in a solvent, Polymerization is carried out using a polymerization initiator and stirring under a nitrogen stream. After the polymerization is completed, the mixture is poured into water to precipitate the polymer, followed by washing, drying, and pulverization to prepare a polymeric urea adhesive. The structure of the polymeric urea adsorbent is considered to be good, as the ratio of carboxyl groups to imidazole groups is considered to be 1 from the charging ratio, and the component represented by general formula (2) is 58% by weight of the total weight. It shows excellent urea adsorption function. In the present invention, the charged amount of an ethylenically unsaturated monomer having a carboxyl group or an ethylenically unsaturated monomer having a group convertible to a carboxyl group,
The charged amount of ethylenically unsaturated monomer having an imidazole group is 5% by weight of the total charged amount, respectively.
If either one is less than this, the urea adsorption ability is poor and is not effective.

本発明における吞着剀に含たれるカルボキシル
基の数ずむミダゟヌル基の数の比はr1カルボ
キシル基の数むミダゟヌル基の数ずする
ず、r10.1乃至であり、奜たしくr1乃至
0.5であり、最も奜たしくはr1である。
The ratio of the number of carboxyl groups to the number of imidazole groups contained in the adsorbent in the present invention is r 1 =(number of carboxyl groups)/(number of imidazole groups), and is preferably r 1 =0.1 to 8. 1 = 2 to
0.5 and most preferably r 1 =1.

r1の時に本発明における尿玠吞着剀は、最
も有効な尿玠吞着胜を瀺す。
When r 1 =1, the urea adsorbent of the present invention exhibits the most effective urea adsorption ability.

r1が0.1より小さい堎合にも、より倧きい堎
合にも尿玠吞着胜は激滅する。
The urea adsorption capacity decreases both when r 1 is smaller than 0.1 and when it is larger than 8.

このものに䞀般匏(2)で瀺される構成成分を導入
するこずにより、曎に䞀局尿玠吞着胜を改良する
こずが可胜ずなる。そのためには、䞀般匏(2)で瀺
される構成成分は党重量の重量以䞊70重量
以䞋である。重量以䞋であるずその効果は期
埅できない。
By introducing the component represented by general formula (2) into this product, it becomes possible to further improve the urea adsorption ability. For this purpose, the component represented by general formula (2) must be at least 2% by weight or more than 70% by weight of the total weight.
It is as follows. If it is less than 2% by weight, the effect cannot be expected.

又、70重量以䞊ずなる、補造された尿玠吞着
剀の吞氎性が増倧し、取り扱いに䞍䟿さを生じ
る。
Moreover, the water absorption of the produced urea adsorbent increases to 70% by weight or more, causing inconvenience in handling.

該尿玠吞着剀を補造するにあた぀お重合開始剀
が䜿甚されるが、特に限定されるこずなく、アゟ
化合物、過酞化物、レドツクス系開始剀等のいず
れも䜿甚するこずができる。䟋えば、アゟ化合物
ずしおは、αα′−アゟビスむ゜ブチロニトリ
ル、2′−アゟビス−−ゞメチルバレ
ロニトリル等があげられ、過酞化物ずしおは、
ゞベンゟむルペルオキシド、ラりロむルペルオキ
シド、ゞ−−ブチルペルオキシド、ゞクミルペ
ルオキシド、−ブチルハむドロペルオキシド、
ゞむ゜プロピルペルオキシドカヌボネむト等があ
げられ、レドツクス開始剀ずしおは、過酞化氎玠
−Fe2+塩、過硫酞塩−亜硫酞氎玠ナトリりム、
クメンヒドロペルオキシド−Fe2+塩、過酞化ベ
ンゟむル−ゞメチルアニリン等があげられる。
A polymerization initiator is used in producing the urea adsorbent, but there is no particular limitation, and any of azo compounds, peroxides, redox initiators, etc. can be used. For example, azo compounds include α,α'-azobisisobutyronitrile, 2,2'-azobis-(2,4-dimethylvaleronitrile), and peroxides include:
dibenzoyl peroxide, lauroyl peroxide, di-t-butyl peroxide, dicumyl peroxide, t-butyl hydroperoxide,
Examples include diisopropyl peroxide carbonate, and redox initiators include hydrogen peroxide-Fe 2+ salt, persulfate-sodium bisulfite,
Examples include cumene hydroperoxide-Fe 2+ salt, benzoyl peroxide-dimethylaniline, and the like.

溶液重合法においお甚いられる溶剀は、単量䜓
が溶解し埗るものであり、重合を阻害しないもの
であれば䜕ら限定されるこずはなく、䟋えば
N′−ゞメチルホルムアミド、N′−ゞメチル
アセトアミド等のアミド系溶剀、ベンれン、トル
゚ン、キシレン等の芳銙族系炭化氎玠、酢酞メチ
ル、酢酞゚チル、酢酞プロピル、酢酞ブチル等の
゚ステル系溶剀、メタノヌル、゚タノヌル、む゜
プロピルアルコヌル、−プロピルアルコヌル、
−ブタノヌル、む゜ブタノヌル、sec−ブタノ
ヌル、−ブタノヌル等のアルコヌル系溶剀、ア
セトン、メチル゚チルケトン、ゞ゚チルケトン等
のケトン系溶剀が䜿甚される。
The solvent used in the solution polymerization method is not limited in any way as long as it can dissolve the monomer and does not inhibit polymerization, such as N,
Amide solvents such as N'-dimethylformamide and N,N'-dimethylacetamide, aromatic hydrocarbons such as benzene, toluene and xylene, ester solvents such as methyl acetate, ethyl acetate, propyl acetate and butyl acetate, methanol , ethanol, isopropyl alcohol, n-propyl alcohol,
Alcohol solvents such as n-butanol, isobutanol, sec-butanol and t-butanol, and ketone solvents such as acetone, methyl ethyl ketone and diethyl ketone are used.

球状の重合䜓粒子を埗るためには、懞濁重合法
もしくは乳化重合法を採甚するこずもでき、これ
らの堎合には氎を溶剀ずし、分散安定剀や界面掻
性剀を甚いお重合せしめるこずが可胜である。
特開昭60−55009号公報、特願昭171760号公報 本発明の吞着剀の重合䜓の分子量は、3000乃至
100䞇、奜たしくは5000乃至10䞇である。
In order to obtain spherical polymer particles, suspension polymerization or emulsion polymerization can be used. In these cases, polymerization can be carried out using water as a solvent and a dispersion stabilizer or surfactant. It is possible.
(Japanese Unexamined Patent Publication No. 1983-55009, Japanese Patent Application No. 171760) The molecular weight of the polymer of the adsorbent of the present invention is 3000 to 3000.
1 million, preferably 5,000 to 100,000.

以䞊のようにしお補造された尿玠吞着剀は、そ
のたた吞着剀ずしお䜿甚するこずが可胜であり、
叉必芁に応じお衚面の改質反応を実斜したり、ヘ
パリンやアルブミンのコヌテむング、プラズマ凊
理等の凊理埌尿玠吞着剀ずしお䜿甚しおもよい。
The urea adsorbent produced as described above can be used as an adsorbent as is,
If necessary, it may be used as a urea adsorbent after carrying out a surface modification reaction, coating with heparin or albumin, plasma treatment, or the like.

〔䜜甚〕[Effect]

本発明における高分子尿玠吞着剀は、高性胜の
尿玠吞着胜を有しおおり100mgdl、尿玠氎溶
æ¶²50mlに0.5の該尿玠吞着剀を入れ、時間浞
挬せしめるこずにより尿玠濃床を25mgdlにたで
枛少させるこずが可胜である。、吞着型人工腎臓
やセンサヌに応甚可胜である。
The polymer urea adsorbent of the present invention has a high urea adsorption capacity (100 mg/dl), and by adding 0.5 g of the urea adsorbent to 50 ml of urea aqueous solution and soaking it for 2 hours, the urea concentration can be reduced to 25 mg. /dl), which can be applied to adsorption-type artificial kidneys and sensors.

〔実斜䟋〕〔Example〕

以䞋、実斜䟋により本発明を具䜓的に説明する
が、本発明はこれら実斜䟋に限定されるものでは
ない。
EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited to these Examples.

実斜䟋  アクリル酞7.5、−ビニルむミダゟヌル9.4
、゚チレングリコヌルメタクリレヌト、
αα′−アゟピスむ゜プチロニトリルAIBN
0.1をN′−ゞメチルホルムアルデヒド
DMF100mlに溶解し、窒玠気流䞋110℃で時
間重合せしめた。その埌少量のAIBNを加え、枛
圧加熱䞋でDMFを留去せしめ、重合反応を完結
させた。重合残留物をの氎の䞭に入れお宀枩
で時間かきたぜた埌、遠心分離機により重合物
を分離し、そのものを曎に氎で回、メタノヌル
で回、アセトンで回掗浄を行い、枛圧䞋50℃
で日也燥せしめた。也燥埌粉砕し、平均粒埄玄
100Όの粒子を埗た。該重合䜓の組成は赀倖線吞
収スペクトルによりカルボキシル基3300〜300
cm-1、1750cm-1ずむミダゟヌル基1550、
1490、1325cm-1の存圚が確認され、その仕蟌み
量からカルボキシル基の数ずむミダゟヌル基の数
の比がず考えられる。カルボキシル基ずむミダ
ゟヌル基は重合䜓内で匱い盞互䜜甚をするが、赀
倖線吞収スペクトルの吞収域から考慮しおランダ
ム状に配眮されおいる。又、該重合䜓は架橋高分
子であり、あらゆる溶剀に䞍溶であるが、氎に察
する膚最床は良奜である。
Example 1 Acrylic acid 7.5g, 1-vinylimidazole 9.4g
g, 2 g of ethylene glycol methacrylate,
α,α′-Azopisisobutyronitrile (AIBN)
0.1 g was dissolved in 100 ml of N,N'-dimethylformaldehyde (DMF) and polymerized at 110° C. for 2 hours under a nitrogen stream. Thereafter, a small amount of AIBN was added, and DMF was distilled off under reduced pressure and heating to complete the polymerization reaction. The polymerization residue was placed in the water from step 1 and stirred at room temperature for 1 hour, and then the polymerization product was separated using a centrifuge, which was further washed twice with water, twice with methanol, and once with acetone. , 50℃ under reduced pressure
I let it dry for a day. After drying, grind to an average particle size of approx.
100Ό particles were obtained. The composition of the polymer was determined by infrared absorption spectrum to show carboxyl groups (3300 to 300
cm -1 , 1750cm -1 ) and imidazole group (1550,
1490, 1325 cm -1 ) was confirmed, and the ratio of the number of carboxyl groups to the number of imidazole groups is considered to be 1 from the amount charged. The carboxyl groups and imidazole groups interact weakly within the polymer, but are arranged randomly in consideration of the absorption range of the infrared absorption spectrum. Further, the polymer is a crosslinked polymer and is insoluble in all solvents, but has a good degree of swelling in water.

該重合䜓粒子をそのたた尿玠吞着剀ずしお甚
い、尿玠吞着量を以䞋の劂くにしお枬定した。
The polymer particles were used as they were as a urea adsorbent, and the amount of urea adsorbed was measured as follows.

100ml尿玠dlの氎溶液50mlに該吞着剀を0.5
入れ、20℃で時間かきたぜを行぀た。その埌遠
心分離し、その䞊柄み液に察しおゞアセチル法に
より尿玠の濃床を比色定量した。日立補䜜所補
150−20型分光光床蚈を甚い480n比色定量し
た。その結果、尿玠濃床が30mg尿玠dlにたで
枛少しおいる事実が分か぀た。比范たでに該吞着
剀の代わりに掻性炭を甚いた堎合には、95mgå°¿
玠dlにたでしか枛少しなか぀た。
0.5g of the adsorbent in 50ml of 100ml urea/dl aqueous solution
and stirred at 20°C for 2 hours. Thereafter, the mixture was centrifuged, and the concentration of urea in the supernatant was determined colorimetrically by the diacetyl method. (Manufactured by Hitachi, Ltd.
Colorimetric determination was carried out at 480 nm using a 150-20 spectrophotometer. ) As a result, it was found that the urea concentration had decreased to 30mg urea/dl. For comparison, when activated carbon was used instead of the adsorbent, the amount decreased to only 95 mg urea/dl.

このようにカルボキシル基の数ずむミダゟヌル
基の数の比がで存圚し、その䞡者のみで構成さ
れおいる重合䜓は非垞に高い尿玠吞着機胜を有し
おいる事実が分か぀た。
It has thus been found that the ratio of the number of carboxyl groups to the number of imidazole groups is 1, and that a polymer composed only of both has a very high urea adsorption function.

尚、本実斜䟋においお、赀倖線吞収スペクトル
は日本分光(æ ª)補−102型 赀倖分光光床蚈を、
玫倖・可芖吞収スペクトルは日立補䜜所(æ ª)補150
−20型 玫倖・可芖分光光床蚈を甚いお枬定し
た。
In this example, the infrared absorption spectrum was measured using a model A-102 infrared spectrophotometer manufactured by JASCO Corporation.
Ultraviolet/visible absorption spectrum is 150 manufactured by Hitachi, Ltd.
Measurements were made using a -20 type ultraviolet/visible spectrophotometer.

実斜䟋  −ビニルむミダゟヌル10、メタクリル酞ク
ロラむド11.0を50mlのトル゚ンに入れ、宀枩で
時間かきたぜを行うず癜色沈柱が生成した。こ
の癜色沈柱はメタクリロむルむミダゟヌル塩であ
り、メタクリロむル基ず−ビニルむミダゟヌル
の察の塩である。該むミダゟヌル塩をろ過
し、100mlのDMFに溶解し、そのものにのゞ
ビニルベンれンず0.1のAIBNを加え、110℃で
時間重合を行぀た。その埌少量のAIBNを加
え、枛圧加熱䞋DMFを留去せしめ、重合反応を
完結させた。重合残留物をの氎䞭に入れ宀枩
で時間かきたぜた埌、炭酞氎玠ナトリりムを二
酞化炭玠が出なくなるたで加え䞭和した。この時
点でカルボキシル基ずむミダゟヌル基が遊離さ
れ、赀倖線吞収スペクトルによりカルボキシル基
ずむミダゟヌル基の存圚が確認された。以埌、実
斜䟋ず同様の方法で分離、粟補、也燥、粉枠を
行い尿玠吞着剀を埗た。該重合䜓はカルボキシル
基ずむミダゟヌル基を含んでおり、その比は仕蟌
み比からず考えられ、曎にゞビニルベンれンに
より架橋された高分子䜓であり、あらゆる溶剀に
䞍溶であるが、氎に察する膚最床は良奜である。
該吞着剀を甚いお尿玠吞着詊隓を実斜した。その
結果、尿玠濃床が30mg尿玠dlにたで枛少しおい
る事実が分か぀た。このように、たずメタクリル
酞クロラむドず−ビニルむミダゟヌルから塩を
合成し重合を行぀た堎合の尿玠吞着剀も非垞に高
い尿玠吞着胜を有しおいる事実が分か぀た。
Example 2 10 g of 1-vinylimidazole and 11.0 g of methacrylic acid chloride were added to 50 ml of toluene and stirred at room temperature for 1 hour to form a white precipitate. This white precipitate is a methacryloyl imidazole salt, which is a 1:1 salt of methacryloyl group and 1-vinylimidazole. The imidazole salt was filtered and dissolved in 100 ml of DMF, to which were added 1 g of divinylbenzene and 0.1 g of AIBN, and polymerization was carried out at 110° C. for 2 hours. Thereafter, a small amount of AIBN was added, and DMF was distilled off under reduced pressure and heating to complete the polymerization reaction. The polymerization residue was placed in water from Step 1 and stirred at room temperature for 5 hours, and then neutralized by adding sodium hydrogen carbonate until no carbon dioxide was released. At this point, the carboxyl group and imidazole group were liberated, and the presence of the carboxyl group and imidazole group was confirmed by infrared absorption spectrum. Thereafter, separation, purification, drying, and powder frame were performed in the same manner as in Example 1 to obtain a urea adsorbent. The polymer contains carboxyl groups and imidazole groups, and the ratio is thought to be 1 based on the charging ratio.It is also a polymer crosslinked with divinylbenzene, and is insoluble in all solvents, but has a high degree of swelling in water. is in good condition.
A urea adsorption test was conducted using the adsorbent. As a result, it was found that the urea concentration had decreased to 30 mg urea/dl. In this way, it has been found that a urea adsorbent obtained by first synthesizing a salt from methacrylic acid chloride and 1-vinylimidazole and then polymerizing it also has a very high urea adsorption capacity.

実斜䟋  −ビニルむミダゟヌル10、アクリル酞7.9
、ポリオキシ゚チレグリコヌルモノメタクリレ
ヌトブレンマヌPE350、数平均分子量400、日
本油脂瀟補20、゚チレングリコヌルゞメタク
リレヌト、AIBN 0.1をDMF100mlに溶解
し、実斜䟋ず同法で尿玠吞着剀を調敎した。赀
倖線吞収スペクトルにより該吞着剀にはカルボキ
シル基、むミダゟヌル基及び氎酞基3500〜3300
cm-1が含たれおいるこずが確認され、仕蟌み比
によりカルボキシル基ずむミダゟヌル基の比が
であり、ポリオキシ゚チレングリコヌル誘導䜓が
党重量の50重量存圚する重合䜓である。曎に架
橋重合䜓であり、あらゆる溶剀に䞍溶であるが、
氎に察する膚最性は良奜であり、実斜䟋のそれ
よりも優れおいる。該吞着剀を甚いお実斜䟋ず
同法で尿玠吞着詊隓を実斜したずころ、25mgå°¿
玠dlにたで枛少しおいる事実が分か぀た。この
ように、ポリオキシ゚チレングリコヌル誘導䜓が
含たれおいる堎合には尿玠吞着胜が改良されるこ
ずが分かる。
Example 3 1-vinylimidazole 10g, acrylic acid 7.9g
g, 20 g of polyoxyethylene glycol monomethacrylate (Blenmar PE350, number average molecular weight 400, manufactured by NOF Corporation), 2 g of ethylene glycol dimethacrylate, and 0.1 g of AIBN were dissolved in 100 ml of DMF, and a urea adsorbent was added in the same manner as in Example 1. It was adjusted. According to the infrared absorption spectrum, the adsorbent contains carboxyl groups, imidazole groups, and hydroxyl groups (3500 to 3300
cm -1 ) was confirmed, and the ratio of carboxyl groups to imidazole groups was 1 depending on the preparation ratio.
It is a polymer in which the polyoxyethylene glycol derivative is present at 50% by weight of the total weight. Furthermore, it is a crosslinked polymer and is insoluble in all solvents, but
The water swelling property is good and better than that of Example 1. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1, it was found that the adsorption amount was reduced to 25 mg urea/dl. Thus, it can be seen that when a polyoxyethylene glycol derivative is contained, the urea adsorption ability is improved.

実斜䟋  メタアクリル酞、−ビニルむミダゟヌル
、ポリオキシ゚チレングリコヌルモノメタク
リレヌトブレンマヌPE350、数平均分子量400、
日本油脂瀟補、4.2、゚チレングリコヌルゞメ
タクリレヌト1.1、AIBN 0.05を100mlの
DMFに溶解し、実斜䟋ず同様の方法で尿玠吞
着剀を調敎した。赀倖線吞収スペクトルにより、
該吞着剀にはカルボキシル基、むミダゟヌル基、
及び氎酞基が含たれおいるこずが確認され、曎に
遊離の−NH基3210cmp-1、鋭い吞収が存圚
するこずが確認された。該重合䜓はその仕蟌み比
により、カルボキシル基ずむミダゟヌル基の比が
であり、ポリオキシ゚チレングリコヌル誘導䜓
が党重量の50重量存圚する重合䜓である。曎
に、架橋重合䜓であり、あらゆる溶剀に䞍溶であ
るが、氎に察する膚最性は良奜である。該吞着剀
を甚いお実斜䟋ず同様な方法で尿玠吞着詊隓を
実斜したずころ、37mg尿玠dlにたで枛少しおい
る事実が分か぀た。このように、むミダゟヌル基
を有する䞍飜和単量䜓ずしお−ビニルむミダゟ
ヌルを甚いた堎合でも、本発明における尿玠吞収
剀は高い吞着胜を瀺すこずが分る。
Example 4 2 g of methacrylic acid, 2 g of 4-vinylimidazole, polyoxyethylene glycol monomethacrylate (Blemmer PE350, number average molecular weight 400,
(manufactured by NOF Corporation), 4.2g, ethylene glycol dimethacrylate 1.1g, AIBN 0.05g in 100ml
A urea adsorbent was prepared by dissolving it in DMF and using the same method as in Example 1. By infrared absorption spectrum,
The adsorbent contains a carboxyl group, an imidazole group,
It was confirmed that hydroxyl groups and hydroxyl groups were contained, and it was further confirmed that a free -NH group (3210 cmp -1 , sharp absorption) was present. This polymer is a polymer in which the ratio of carboxyl groups to imidazole groups is 1 depending on the charging ratio, and the polyoxyethylene glycol derivative is present in an amount of 50% by weight of the total weight. Furthermore, it is a crosslinked polymer and is insoluble in all solvents, but has good swelling properties in water. When a urea adsorption test was carried out using the adsorbent in the same manner as in Example 1, it was found that the urea adsorption was reduced to 37 mg urea/dl. Thus, it can be seen that even when 4-vinylimidazole is used as the unsaturated monomer having an imidazole group, the urea absorbent of the present invention exhibits high adsorption capacity.

実斜䟋  メチルメタクリレヌト、−ビニルむミダ
ゟヌル4.7、アクリル酞3.6、゚チレングリコ
ヌルゞメタクリレヌト、AIBN 0.1を
DMF100mlに溶解し、実斜䟋ず同法で尿玠吞着
剀を調補した。赀倖線吞収スペクトルにより、該
吞着剀にはカルボキシル基、むミダゟヌル基及び
メチルメタクリレヌト重合残基、1735cm
-1が含たれおいる事が確認され、又その仕蟌み
比によりカルボキシル基ずむミダゟヌル基ずメチ
ルメタクリレヌト重合残基の数が察察の比
で構成される重合䜓である。該重合䜓は架橋高分
子であり、あらゆる溶剀に䞍溶であるが、氎に察
する膚最性は良奜である。該吞着剀を甚いお実斜
䟋ず同法で尿玠吞着詊隓を実斜したずころ、35
mg尿玠dlにたで枛少しおいる事実が分぀た。
Example 5 5 g of methyl methacrylate, 4.7 g of 1-vinylimidazole, 3.6 g of acrylic acid, 1 g of ethylene glycol dimethacrylate, and 0.1 g of AIBN.
A urea adsorbent was prepared by dissolving in 100 ml of DMF and using the same method as in Example 1. Infrared absorption spectra revealed that the adsorbent contains carboxyl groups, imidazole groups, and methyl methacrylate polymerization residues (C=O, 1735 cm
-1 ), and it is a polymer composed of carboxyl groups, imidazole groups, and methyl methacrylate polymer residues in a 1:1:1 ratio depending on the charging ratio. The polymer is a crosslinked polymer and is insoluble in all solvents, but has good swelling properties in water. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1, 35
It was found that the concentration had decreased to mg urea/dl.

又、䞊蚘メチルメタクリレヌトの代りにビニル
アセテヌト3.2を甚いお、カルボキシル基の数
ずむミダゟヌル基の数ずビニルアセテヌト重合残
基の数が察察で構成される重合䜓を同法で
合成し尿玠吞着剀を調補した。該吞着剀を甚いお
実斜䟋ず同法で尿玠吞着詊隓を実斜したずこ
ろ、38mg尿玠dlにたで枛少しおいる事実が分぀
た。このように、カルボキシル基、むミダゟヌル
基以倖に他の゚チレン性䞍飜和単量䜓重合残基が
存圚した堎合でも、本発明における尿玠吞着剀は
高い吞着胜を瀺すこずが分る。
In addition, using 3.2 g of vinyl acetate instead of the above methyl methacrylate, a polymer in which the number of carboxyl groups, the number of imidazole groups, and the number of vinyl acetate polymerization residues were in a 1:1:1 ratio was synthesized by the same method. A urea adsorbent was prepared. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1, it was found that the adsorption amount was reduced to 38 mg urea/dl. Thus, it can be seen that the urea adsorbent of the present invention exhibits high adsorption capacity even when other ethylenically unsaturated monomer polymerization residues are present in addition to carboxyl groups and imidazole groups.

実斜䟋  スチレン30、−ビニルむミダゟヌル9.4、
アクリル酞7.5、AIBN 0.1をDMF100mlに溶
解し、実斜䟋ず同法で尿玠吞着剀を調補した。
該吞着剀は非架橋重合䜓であり、DMF、ゞメチ
ルアセトアミド等の溶剀には可溶であるが、氎、
メタノヌル、゚タノヌルには䞍溶の重合䜓であ
る。又、該吞着剀の数平均分子量は玄12000であ
り、赀倖線吞収スペクトルにより、カルボキシル
基ずむミダゟヌル基の存圚が確認され、又その非
は仕蟌み比からず考えられる。該吞着剀を甚い
お実斜䟋ず同法で尿玠吞着詊隓を実斜したこ
ろ、41mg尿玠dlにたで枛少しおいる事実が分぀
た。本実斜䟋に甚いた吞着剀は、ポリスチレンを
䞻成分ずする非架橋重合䜓であり、架橋重合䜓に
比しお氎に察する膚最性は倧であり、このものに
おいおも尿玠吞着胜は優れおいるこずが分る。
Example 6 30 g of styrene, 9.4 g of 1-vinylimidazole,
A urea adsorbent was prepared in the same manner as in Example 1 by dissolving 7.5 g of acrylic acid and 0.1 g of AIBN in 100 ml of DMF.
The adsorbent is a non-crosslinked polymer and is soluble in solvents such as DMF and dimethylacetamide, but is soluble in water,
It is a polymer that is insoluble in methanol and ethanol. Further, the number average molecular weight of the adsorbent is about 12,000, and the presence of carboxyl groups and imidazole groups was confirmed by infrared absorption spectrum, and their absence is considered to be 1 based on the charging ratio. When a urea adsorption test was carried out using the adsorbent in the same manner as in Example 1, it was found that the adsorption amount had decreased to 41 mg urea/dl. The adsorbent used in this example is a non-crosslinked polymer whose main component is polystyrene, which has a higher swelling property in water than a crosslinked polymer, and also has excellent urea adsorption ability. I understand.

比范䟋 −ビニルむミダゟヌル10、゚チレングリコ
ヌルゞメタクリレヌト、AIBN 0.03を
DMF50mlに溶解し、実斜䟋ず同法で重合を行
い尿玠吞着剀を調補した。該吞着剀を甚いお実斜
䟋ず同法で尿玠吞着詊隓を実斜でしたずころ、
尿玠濃床は詊隓埌も100mg尿玠dlであり、党く
倉化は芋られなか぀た。該重合䜓はカルボキシル
基は無く、むミダゟヌル基のみであり、党く尿玠
吞着胜が無い事実が分぀た。又、該重合䜓はあら
ゆる重合䜓に䞍溶であるが、氎に察する膚玔性も
悪く、尿玠吞着剀に適しおいない。又、䞊蚘−
ビニルむミダゟヌルの代りにアクリル酞10を甚
いお実斜䟋ず同法で重合を行い尿玠吞着剀を調
補した。該吞着剀を甚いお実斜䟋ず同法で尿玠
吞着詊隓を実斜したずころ、吞湿性が非垞に倧で
あり、取り扱いに困難な䞊、尿玠濃床は60mgå°¿
玠dlにたでしか枛少しない事実が分぀た。該重
合䜓はむミダゟヌル基は無く、カルボキシル基の
みである。
Comparative example 1-vinylimidazole 10g, ethylene glycol dimethacrylate 1g, AIBN 0.03g
It was dissolved in 50 ml of DMF and polymerized in the same manner as in Example 1 to prepare a urea adsorbent. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1,
The urea concentration remained 100 mg urea/dl even after the test, and no change was observed. It was found that the polymer had no carboxyl groups, only imidazole groups, and had no urea adsorption ability at all. Further, although this polymer is insoluble in all polymers, it also has poor swelling property in water and is not suitable as a urea adsorbent. Also, above 1-
A urea adsorbent was prepared by polymerizing in the same manner as in Example 1 using 10 g of acrylic acid instead of vinyl imidazole. When a urea adsorption test was carried out using the adsorbent in the same manner as in Example 1, it was found that it had very high hygroscopicity and was difficult to handle, and that the urea concentration could only be reduced to 60 mg urea/dl. Divided. This polymer has no imidazole group and only carboxyl groups.

これらの事実からカルボキシル基のみ、もしく
はむミダゟヌル基のみ存圚する重合䜓は、本発明
における尿玠吞着剀ずしお䞍適であるこずが分
る。
These facts indicate that polymers containing only carboxyl groups or only imidazole groups are unsuitable as urea adsorbents in the present invention.

〔発明の効果〕〔Effect of the invention〕

本発明の高分子尿玠吞着剀は、カルボキシル基
及びむミダゟヌル基を共に含有するものであり、
高性胜の尿玠機胜を有し、尿玠の吞着、分離の必
芁なあらゆる分野に適甚でき、特に吞着型人工腎
臓やセンサヌに応甚可胜である。
The polymer urea adsorbent of the present invention contains both a carboxyl group and an imidazole group,
It has a high-performance urea function and can be applied to all fields that require urea adsorption and separation, and is particularly applicable to adsorption-type artificial kidneys and sensors.

Claims (1)

【特蚱請求の範囲】  カルボキシル基ず䞀般匏(1)で瀺されるむミダ
ゟヌル基 匏䞭、R1は氎玠たたは炭玠数以䞋の炭化氎
玠基を衚す。 を構成成分ずしお含有し、必芁に応じお架橋剀に
より架橋した゚チレン性䞍飜和単量䜓の重合䜓で
あ぀お、カルボキシル基の数ずむミダゟヌル基の
数ずの比カルボキシル基むミダゟヌル基が
0.1乃至0.8であるこずを特城ずする高分子尿玠吞
着剀。  カルボキシル基、 䞀般匏(1)で瀺されるむミダゟヌル基 匏䞭、R1は氎玠たたは炭玠数以䞋の炭化氎
玠基を衚す。、及び 䞀般匏(2) 〔−CH2−o−〕nR2 (2) 匏䞭は乃至の敎数、は以䞊の敎数を
衚し、R2は氎玠たたはメチル基を衚す。で瀺さ
れるポリオキシアルキレングリコヌル誘導䜓基 を構成成分ずしお含有し、必芁に応じお架橋剀に
より架橋した゚チレン性䞍飜和単量䜓の重合䜓で
あ぀お、カルボキシル基の数ずむミダゟヌル基の
数ずの比カルボキシル基むミダゟヌル基
が、0.1乃至8.0であるこずを特城ずする高分子尿
玠吞着剀。
[Claims] 1. Carboxyl group and imidazole group represented by general formula (1) (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.) A polymer of ethylenically unsaturated monomers that contains as a constituent component and is crosslinked with a crosslinking agent as necessary. , the ratio of the number of carboxyl groups to the number of imidazole groups (carboxyl group/imidazole group) is
A polymer urea adsorbent characterized by having a molecular weight of 0.1 to 0.8. 2 carboxyl group, imidazole group represented by general formula (1) (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.), and General formula (2) [-(CH 2 -) o O-] n R 2 (2) (In the formula, n is Contains a polyoxyalkylene glycol derivative group represented by an integer of 2 to 5, m represents an integer of 3 or more, and R2 represents hydrogen or a methyl group as a constituent component, and can be crosslinked with a crosslinking agent as necessary. A polymer of ethylenically unsaturated monomers, the ratio of the number of carboxyl groups to the number of imidazole groups (carboxyl group/imidazole group)
is from 0.1 to 8.0.
JP61202661A 1986-08-30 1986-08-30 High-molecular urea adsorbent Granted JPS6359353A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP61202661A JPS6359353A (en) 1986-08-30 1986-08-30 High-molecular urea adsorbent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61202661A JPS6359353A (en) 1986-08-30 1986-08-30 High-molecular urea adsorbent

Publications (2)

Publication Number Publication Date
JPS6359353A JPS6359353A (en) 1988-03-15
JPH0443697B2 true JPH0443697B2 (en) 1992-07-17

Family

ID=16461047

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61202661A Granted JPS6359353A (en) 1986-08-30 1986-08-30 High-molecular urea adsorbent

Country Status (1)

Country Link
JP (1) JPS6359353A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013528103A (en) * 2010-06-07 2013-07-08 フレれニりス メディカル ケア ホヌルディングス むンコヌポレむテッド Urea adsorbent

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861473B2 (en) 2003-02-28 2005-03-01 Baxter International Inc. Macromolecular ketoaldehydes
JP5233146B2 (en) * 2007-03-30 2013-07-10 栗田工業株匏䌚瀟 ORGANIC UREA COMPOUND ADSORBENT, ORGANIC UREA COMPOUND ADSORBING DEVICE, AND ORGANIC UREA COMPOUND TREATMENT METHOD
US8220643B2 (en) * 2008-06-06 2012-07-17 Fresenius Medical Care Holdings, Inc. Urea sorbent
US20120032093A1 (en) 2010-08-03 2012-02-09 Kemira Chemicals Inc. Tagged scale inhibitor compositions and methods of inhibiting scale

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013528103A (en) * 2010-06-07 2013-07-08 フレれニりス メディカル ケア ホヌルディングス むンコヌポレむテッド Urea adsorbent

Also Published As

Publication number Publication date
JPS6359353A (en) 1988-03-15

Similar Documents

Publication Publication Date Title
JP5717766B2 (en) Thermoplastic nanocomposite materials based on nanocrystalline cellulose (NCC)
US6303702B1 (en) Method of producing material for purification of physiological liquids of organism
CN105085829A (en) Preparation method of macroporous adsorbent resin for toxin substance adsorption
CN117123198B (en) A method for modifying blood purification adsorption materials
CA1274341A (en) Water absorbing resins, their manufacture and their use in the production of aqueous fluid absorbent articles
JPH0443697B2 (en)
JPH05279411A (en) Biologically active substance bonded to carrier
US7112620B2 (en) Hemocompatible polymer systems & related methods
EP0217062B1 (en) Urea adsorbent
US20050159508A1 (en) Hemocompatible coated polymer and related one-step methods
JP3626774B2 (en) High density high surface area adsorbent
JP3285441B2 (en) Adsorbent for lowering plasma viscosity of vasoocclusive disease plasma and apparatus for lowering plasma viscosity
JPS6361007A (en) Urea-decomposing metal complex resin
JPH0117412B2 (en)
JPH04247236A (en) Highly cross-linked pearl-like hydrophobic support material capable of being activated, method for modifying said support material and method for adsorbing biologically active substance from watery liouid or chromatograph- ing for removal of large amount of said substance
JP3323558B2 (en) Manufacturing method of super absorbent resin
JP3119897B2 (en) Method for producing water-soluble or water-swellable polymer
US20240197977A1 (en) Improved immune response and decreased immunoparalysis with immunomodulating treatment
JPH0549337B2 (en)
CN101596464A (en) A kind of recyclable esterification polymer catalyst, preparation method and application
JPH0834894A (en) Polyacrylic acid complex
JPH0141383B2 (en)
JPH0243948A (en) Adsorbent
CN119524812A (en) Low-density lipoprotein adsorbent and preparation method thereof
CN121927116A (en) A hydrogen peroxide scavenging enzyme/SOD complex material and its application